Difficulty: Medium
Average Score: 92%
Practice
Choose the drug which has a direct effect on platelet membrane to inhibit aggregation, release reaction and to improve platelet survival in extra-corporeal circulation
Correct answer
B
Rationale
The correct answer is B) Ticlopidine. Ticlopidine is a thienopyridine antiplatelet agent that has a direct effect on the platelet membrane to inhibit aggregation, release reaction, and improve platelet survival in extra-corporeal circulation.
Ticlopidine works by inhibiting the binding of adenosine diphosphate (ADP) to its platelet receptor, thereby preventing platelet activation and aggregation. This mechanism of action is distinct from the other options provided.
A) Dipyridamole works by inhibiting platelet aggregation through a different mechanism involving adenosine uptake inhibition and phosphodiesterase inhibition.
C) Aspirin inhibits platelet aggregation by irreversibly inhibiting cyclooxygenase, thereby preventing the formation of thromboxane A2, a potent platelet aggregator.
D) Sulfinpyrazone is a uricosuric agent that also has antiplatelet effects but works through a different mechanism compared to Ticlopidine.
In an educational context, understanding the mechanisms of action of different cardiovascular pharmacology drug classes is essential for healthcare professionals to make informed clinical decisions when managing patients with cardiovascular conditions. Knowing the specific effects of each drug on platelet function helps in tailoring treatment regimens to achieve optimal outcomes while minimizing adverse effects.
Ticlopidine works by inhibiting the binding of adenosine diphosphate (ADP) to its platelet receptor, thereby preventing platelet activation and aggregation. This mechanism of action is distinct from the other options provided.
A) Dipyridamole works by inhibiting platelet aggregation through a different mechanism involving adenosine uptake inhibition and phosphodiesterase inhibition.
C) Aspirin inhibits platelet aggregation by irreversibly inhibiting cyclooxygenase, thereby preventing the formation of thromboxane A2, a potent platelet aggregator.
D) Sulfinpyrazone is a uricosuric agent that also has antiplatelet effects but works through a different mechanism compared to Ticlopidine.
In an educational context, understanding the mechanisms of action of different cardiovascular pharmacology drug classes is essential for healthcare professionals to make informed clinical decisions when managing patients with cardiovascular conditions. Knowing the specific effects of each drug on platelet function helps in tailoring treatment regimens to achieve optimal outcomes while minimizing adverse effects.